SMO and non-small cell lung carcinoma: Another study showed that mammalian HERC4 is downregulated and negatively correlated with Smo in non-small cell lung cancer (NSCLC) patient samples and that knockdown of HERC4 activated Hh pathway and promoted NSCLC cell proliferation (Sun et al., 2019).